Institution: | 1. Department of Medicine, Medical College of Wisconsin, Milwaukee;2. Department of Anesthesiology, University of Colorado School of Medicine, Aurora;3. Department of Medicine, Medical College of Wisconsin, Milwaukee;4. Department of Hospital Medicine, Cleveland Clinic Lerner College of Medicine, OH;5. Department of Anesthesiology, The Ohio State Wexner Medical Center, Columbus;6. Division of Endocrinology, Mayo Clinic, Rochester, MN;7. Division of General Internal Medicine, Mayo Clinic, Rochester, MN;8. Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital, Boston, MA;9. Division of General Internal Medicine, Mayo Clinic, Rochester, MN |
Abstract: | Perioperative medical management is challenging due to the rising complexity of patients presenting for surgical procedures. A key part of preoperative optimization is appropriate management of long-term medications, yet guidelines and consensus statements for perioperative medication management are lacking. Available resources utilize the recommendations derived from individual studies and do not include a multidisciplinary focus or formal consensus. The Society for Perioperative Assessment and Quality Improvement (SPAQI) identified a lack of authoritative clinical guidance as an opportunity to utilize its multidisciplinary membership to improve evidence-based perioperative care. SPAQI seeks to provide guidance on perioperative medication management that synthesizes available literature with expert consensus. The aim of this Consensus Statement is to provide practical guidance on the preoperative management of endocrine, hormonal, and urologic medications. A panel of experts with anesthesiology, perioperative medicine, hospital medicine, general internal medicine, and medical specialty experience was drawn together and identified the common medications in each of these categories. The authors then utilized a modified Delphi approach to critically review the literature and generate consensus recommendations. |